advertisement
2.1 Conjunctiva (1056)
Showing records 1 to 25
Display only abstracts from IGR 19-3 in classification 2.1 Conjunctiva
Search within classification 2.1 Conjunctiva94838 Relationship between OSDI score and biomicroscopic ocular surface damages in glaucomatous patients treated with preserved antiglaucomatous eye drops
Lajmi H
Journal Français d'Ophtalmologie 2021; 44: 1326-1331 (IGR: 22-2)
94658 Brimonidine related acute follicular conjunctivitis: Onset time and clinical presentations, a long-term follow-up
Yeh PH
Medicine 2021; 100: e26724 (IGR: 22-2)
94856 Risk Factors for Ocular Surface Disease in Tunisian Users of Preserved Antiglaucomatous Eye Drops
Lajmi H
Journal of current ophthalmology 2021; 33: 128-135 (IGR: 22-2)
94658 Brimonidine related acute follicular conjunctivitis: Onset time and clinical presentations, a long-term follow-up
Cheng YC
Medicine 2021; 100: e26724 (IGR: 22-2)
94856 Risk Factors for Ocular Surface Disease in Tunisian Users of Preserved Antiglaucomatous Eye Drops
Hmaied W
Journal of current ophthalmology 2021; 33: 128-135 (IGR: 22-2)
94838 Relationship between OSDI score and biomicroscopic ocular surface damages in glaucomatous patients treated with preserved antiglaucomatous eye drops
Chelly Z
Journal Français d'Ophtalmologie 2021; 44: 1326-1331 (IGR: 22-2)
94658 Brimonidine related acute follicular conjunctivitis: Onset time and clinical presentations, a long-term follow-up
Shie SS
Medicine 2021; 100: e26724 (IGR: 22-2)
94856 Risk Factors for Ocular Surface Disease in Tunisian Users of Preserved Antiglaucomatous Eye Drops
Achour BB
Journal of current ophthalmology 2021; 33: 128-135 (IGR: 22-2)
94838 Relationship between OSDI score and biomicroscopic ocular surface damages in glaucomatous patients treated with preserved antiglaucomatous eye drops
Choura R
Journal Français d'Ophtalmologie 2021; 44: 1326-1331 (IGR: 22-2)
94856 Risk Factors for Ocular Surface Disease in Tunisian Users of Preserved Antiglaucomatous Eye Drops
Zahaf A
Journal of current ophthalmology 2021; 33: 128-135 (IGR: 22-2)
94838 Relationship between OSDI score and biomicroscopic ocular surface damages in glaucomatous patients treated with preserved antiglaucomatous eye drops
Mansour KB
Journal Français d'Ophtalmologie 2021; 44: 1326-1331 (IGR: 22-2)
94658 Brimonidine related acute follicular conjunctivitis: Onset time and clinical presentations, a long-term follow-up
Lee YS; Shen SC
Medicine 2021; 100: e26724 (IGR: 22-2)
94838 Relationship between OSDI score and biomicroscopic ocular surface damages in glaucomatous patients treated with preserved antiglaucomatous eye drops
Hmaied W
Journal Français d'Ophtalmologie 2021; 44: 1326-1331 (IGR: 22-2)
94658 Brimonidine related acute follicular conjunctivitis: Onset time and clinical presentations, a long-term follow-up
Chen HS; Wu WC; Su WW
Medicine 2021; 100: e26724 (IGR: 22-2)
92109 Corneal epithelium and limbal region alterations due to glaucoma medications evaluated by anterior segment optic coherence tomography: a case-control study
Güçlü H
Cutaneous and Ocular Toxicology 2021; 40: 85-94 (IGR: 22-1)
92698 Critical role of mass spectrometry proteomics in tear biomarker discovery for multifactorial ocular diseases (Review)
Ma JYW
International Journal of Molecular Medicine 2021; 47: (IGR: 22-1)
92071 New strategies for the management of ocular surface disease in glaucoma patients
Voicu L
Current Opinions in Ophthalmology 2021; 32: 134-140 (IGR: 22-1)
92408 Effect of steroid eyedrops after trabeculectomy in glaucoma patients: a keratograph analysis
Fares NT
Arquivos Brasileiros de Oftalmologia 2021; 84: 345-351 (IGR: 22-1)
92623 TGFβ1, MMPs and cytokines profiles in ocular surface: Possible tear biomarkers for pseudoexfoliation
Sahay P
PLoS ONE 2021; 16: e0249759 (IGR: 22-1)
92384 Tear Film Cytokine Profile of Patients With the Boston Keratoprosthesis Type 1: Comparing Patients With and Without Glaucoma
Geoffrion D
Investigative Ophthalmology and Visual Science 2021; 62: 20 (IGR: 22-1)
92066 Dry eye disease among Glaucoma patients on topical hypotensive medications, in a tertiary hospital, Ethiopia
Sahlu M
BMC Ophthalmology 2021; 21: 155 (IGR: 22-1)
92698 Critical role of mass spectrometry proteomics in tear biomarker discovery for multifactorial ocular diseases (Review)
Sze YH
International Journal of Molecular Medicine 2021; 47: (IGR: 22-1)
92066 Dry eye disease among Glaucoma patients on topical hypotensive medications, in a tertiary hospital, Ethiopia
Giorgis AT
BMC Ophthalmology 2021; 21: 155 (IGR: 22-1)
92623 TGFβ1, MMPs and cytokines profiles in ocular surface: Possible tear biomarkers for pseudoexfoliation
Reddy S
PLoS ONE 2021; 16: e0249759 (IGR: 22-1)
92384 Tear Film Cytokine Profile of Patients With the Boston Keratoprosthesis Type 1: Comparing Patients With and Without Glaucoma
Robert MC
Investigative Ophthalmology and Visual Science 2021; 62: 20 (IGR: 22-1)
